Cargando…

Case Report: Psychiatric Symptoms Associated With the Moderna mRNA COVID-19 Vaccine Administration and Their Resolution

This case report describes the sudden presentation and successful cessation of psychiatric symptoms following the first administration of the Moderna mRNA vaccine against the SARS-CoV-2 virus during early 2021. The process of discovery of symptoms is described, along with an empirical procedure whic...

Descripción completa

Detalles Bibliográficos
Autor principal:	Helman, Daniel S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099908/ https://www.ncbi.nlm.nih.gov/pubmed/37065637 http://dx.doi.org/10.1177/11795476231166626

Ejemplares similares

Neuro-Ophthalmologic Symptoms Associated With the Moderna mRNA COVID-19 Vaccine: A Case Report
por: Raxwal, Tejas, et al.
Publicado: (2022)

Acquired Angioedema Acute Attack After Administration of the Moderna COVID-19 (mRNA-1273) Vaccine
por: Graziani, Alessandro, et al.
Publicado: (2023)

Bullous Pemphigoid Following the Moderna mRNA-1273 Vaccine
por: Desai, Amar D, et al.
Publicado: (2022)

Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine
por: Malayala, Srikrishna V, et al.
Publicado: (2021)

New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination
por: Kaminetsky, Joshua, et al.
Publicado: (2021)

Frailty and Age Impact Immune Responses to Moderna COVID-19 mRNA Vaccine
por: Semelka, Charles T., et al.
Publicado: (2022)

De novo vasculitis after mRNA-1273 (Moderna) vaccination
por: Anderegg, Manuel A., et al.
Publicado: (2021)

Acute Extensive Deep Vein Thrombosis After Heterogeneous Administration of Moderna mRNA Booster Vaccine: A Case Report
por: Alarmanazi, Farrah, et al.
Publicado: (2022)

Guillain‐Barré syndrome after mRNA‐1273 (Moderna) COVID‐19 vaccination: A case report
por: Anjum, Zauraiz, et al.
Publicado: (2022)

2357. Descriptive Analyses of mRNA-1273 (Moderna COVID-19 vaccine) Spontaneous Reports by Geographic Regions
por: Emile-Backer, Magalie, et al.
Publicado: (2023)

Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose
por: Tuong, Linh-An C, et al.
Publicado: (2021)

Immune Thrombocytopenia Following Booster Dose of the Moderna mRNA-1273 Vaccine
por: Breetz, Katherine A, et al.
Publicado: (2022)

Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination
por: Wang, Samuel S.Y.
Publicado: (2022)

Frailty impacts immune responses to Moderna COVID-19 mRNA vaccine in older adults
por: Semelka, Charles T., et al.
Publicado: (2023)

Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions
por: Haq, Hannah N., et al.
Publicado: (2022)

Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report
por: Kong, Joyce, et al.
Publicado: (2021)

Adult‐onset Still's disease following mRNA‐1273 Moderna COVID‐19 vaccination: A case report
por: Iwata, Masahiro, et al.
Publicado: (2022)

Bell's palsy as a possible complication of mRNA-1273 (Moderna) vaccine against COVID-19
por: Poudel, Sujan, et al.
Publicado: (2022)

2336. General Safety Profile of mRNA-1273 (Moderna COVID-19 Vaccine) in the Elderly Population
por: Anteyi, Kate, et al.
Publicado: (2023)

Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Central retinal artery occlusion after Moderna mRNA-1273 vaccination
por: Chow, Sin Yu, et al.
Publicado: (2022)

Subacute Thyroiditis After Receiving the mRNA COVID-19 Vaccine (Moderna): The First Case Report and Literature Review in Korea
por: Jhon, Min, et al.
Publicado: (2022)

Acute tolerance of Moderna mRNA-1273 vaccine against COVID-19 in patients with cancer treated with radiotherapy
por: Scoccianti, Silvia, et al.
Publicado: (2021)

Paucisymptomatic COVID-19 in lung transplant recipient following two doses of mRNA-1273 (Moderna) vaccine
por: Marinelli, Tina, et al.
Publicado: (2021)

Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination: Author's response
por: Pereson, Matías J., et al.
Publicado: (2022)

Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines
por: Xia, Xuhua
Publicado: (2021)

Pityriasis rosea after Moderna mRNA‐1273 vaccine: A case series
por: Martora, Fabrizio, et al.
Publicado: (2021)

De-novo Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Following the mRNA-1273 (Moderna) Vaccine for COVID-19
por: Feghali, Elio Junior, et al.
Publicado: (2021)

A severe case of rhabdomyolysis after Moderna mRNA anti‐COVID‐19 vaccine with a literature review
por: Sheka, Maria, et al.
Publicado: (2023)

Altered mental status and pronounced febrile response after second mRNA-1273 (Moderna) COVID-19 vaccine administration in a patient with previously documented COVID-19 infection
por: Hilaire, Patrick Shamell, et al.
Publicado: (2021)

Sensitization to trometamol in patients with delayed local reactions after administration of the Moderna mRNA-1273 vaccine against SARS-CoV-2
por: Davila-Fernandez, Galicia, et al.
Publicado: (2022)

The Effect of Third Dose of Pfizer/BioNTech and Moderna COVID-19 mRNA Vaccines on IgG Antibody Titers
por: Khuc, Thao A, et al.
Publicado: (2023)

Developmental Status of the Potential Vaccines for the Mitigation of the COVID-19 Pandemic and a Focus on the Effectiveness of the Pfizer-BioNTech and Moderna mRNA Vaccines
por: Noor, Rashed
Publicado: (2021)

Unusual Presentation of Acute Perimyocarditis Following SARS-COV-2 mRNA-1237 Moderna Vaccination
por: Khogali, Fatima, et al.
Publicado: (2021)

Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination
por: Channa, Leelakrishna, et al.
Publicado: (2021)

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
por: Holzworth, Amy, et al.
Publicado: (2021)

Severe Aplastic Anemia After Receiving SARS-CoV-2 Moderna mRNA Vaccination
por: Sridhara, Srilekha, et al.
Publicado: (2022)

Case mistaken for leukemia after mRNA COVID-19 vaccine administration: A case report
por: Lee, Seul Bi, et al.
Publicado: (2022)

A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®
por: Speich, Benjamin, et al.
Publicado: (2021)

Comparison of BNT162b2 (Pfizer–BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients
por: Kaiser, Robert A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k424tue8br94lj4183jahs5kon